Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2026)

Incannex Healthcare's (IXHL) quarterly Shares Outstanding (Weighted Average) came in at $12.3 million in Q1 2026, up 1786.94% year-on-year from $654418.0 in Q1 2025, and down 96.47% quarter-over-quarter from $349.5 million in Q4 2025.

Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $12.3 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $12.3 million, up 1786.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 1786.94% YoY), and the FY2025 annual result was $34.5 million, up 113.15% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $12.3 million for Q1 2026 at Incannex Healthcare, down from $349.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.2 billion in Q2 2022 to a low of $654418.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $15.9 million (2023), against an average of $136.2 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) surged 11811.54% in 2022 and slumped 98.71% in 2023, its largest moves.
  • Incannex Healthcare's Shares Outstanding (Weighted Average) stood at $14.9 million in 2022, then advanced by 6.52% to $15.9 million in 2023, then climbed by 10.65% to $17.6 million in 2024, then soared by 1889.75% to $349.5 million in 2025, then slumped by 96.47% to $12.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $12.3 million (Q1 2026), $349.5 million (Q4 2025), and $310.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Incannex Healthcare 47.42 Mn 47.42 Mn - 12.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.35 Mn
Dec 31, 2025 349.46 Mn
Sep 30, 2025 310.31 Mn
Jun 30, 2025 34.45 Mn
Mar 31, 2025 654,418.00
Dec 31, 2024 17.56 Mn
Sep 30, 2024 17.64 Mn
Jun 30, 2024 16.16 Mn
Mar 31, 2024 15.87 Mn
Dec 31, 2023 15.87 Mn
Sep 30, 2023 15.87 Mn
Jun 30, 2023 15.38 Mn
Mar 31, 2023 15.22 Mn
Dec 31, 2022 14.90 Mn
Jun 30, 2022 1.19 Bn
Jun 30, 2021 10.00 Mn
Jun 30, 2020 5.75 Mn